S0108 Bevacizumab in Treating Patients With Non-Hodgkin's Lymphoma

Clinical trial NCT00016094 · COMPLETED

Trial details

NCT number: NCT00016094
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Anaplastic Large Cell Lymphoma Recurrent Adult Burkitt Lymphoma Recurrent Adult Diffuse Large Cell Lymphoma Recurrent Mantle Cell Lymphoma

Start date: 2001-04-01
Primary completion: 2005-08-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.